U.S. Markets open in 7 hrs 34 mins

Twist Bioscience Corporation (TWST)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
75.97+9.48 (+14.26%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close78.79
Open78.21
Bid0.00 x 800
Ask76.09 x 1100
Day's Range72.80 - 78.96
52 Week Range18.52 - 79.72
Volume805,278
Avg. Volume541,835
Market Cap3.393B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-4.05
Earnings DateAug 06, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est76.67
  • Emily Leproust, Ph.D., to Receive 2020 Rosalind Franklin Award
    Business Wire

    Emily Leproust, Ph.D., to Receive 2020 Rosalind Franklin Award

    Twist Bioscience (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that its CEO and co-founder, Emily M. Leproust, Ph.D., will receive the 2020 Rosalind Franklin Award for Leadership at the Biotechnology Innovation Organization (BIO) IMPACT conference. The award will be presented on Tuesday, September 22, 2020 during a virtual fireside chat with Julianna Lemieux of Genetic Engineering News and the Rosalind Franklin Society.

  • Shareholders Are Thrilled That The Twist Bioscience (NASDAQ:TWST) Share Price Increased 107%
    Simply Wall St.

    Shareholders Are Thrilled That The Twist Bioscience (NASDAQ:TWST) Share Price Increased 107%

    It might be of some concern to shareholders to see the Twist Bioscience Corporation (NASDAQ:TWST) share price down 13...

  • Twist Bioscience to Present at Upcoming Virtual Investor Conferences
    Business Wire

    Twist Bioscience to Present at Upcoming Virtual Investor Conferences

    Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will present at the following upcoming virtual investor conferences: